AstraZeneca Annual Review 2005 - AstraZeneca Annual Reports

41DIRECTORS’ EMOLUMENTS IN 2005The aggregate remuneration, excluding pension contributions and the value of share options and performance share plan awards, paid to or accrued for allDirectors and officers of the Company for services in all capacities during the year ended 31 December 2005 was £11 million ($19 million).Remuneration of individual Directors is set out below in sterling and US dollars. All salaries, fees, bonuses and other benefits for Directors areestablished in sterling, save for David Brennan’s salary, which for 2005 was established in US dollars.Salary Bonuses Taxable Total Total Totaland fees Cash Shares 6 benefits Other 2005 2004 2003Sterling £’000 £’000 £’000 £’000 £’000 £’000 £’000 £’000Louis Schweitzer 260 – – – – 260 31 4 N/ASir Tom McKillop 997 834 417 2 3 1 2,253 1,411 1,790David R Brennan 337 5 251 5 125 5 84 5 22 5 819 5 N/A N/AJohn Patterson 469 350 175 7 48 1,049 N/A N/AJonathan Symonds 577 398 199 8 87 2 1,269 970 1,071Sir Peter Bonfield 82 – – – – 82 76 74John Buchanan 69 – – – – 69 61 53Jane Henney 57 – – – – 57 54 49Michele Hooper 49 – – – – 49 43 19 4Joe Jimenez 49 – – – – 49 43 19 4Håkan Mogren 100 – – – – 100 479 3 1,246Erna Möller 57 – – – – 57 54 49Dame Bridget Ogilvie 57 – – – – 57 54 49Marcus Wallenberg 49 – – – – 49 46 46Former DirectorsÅke Stavling – – – – 36 7 36 7 435 7 489Others – – – – – – 269 305Total 3,209 1,833 916 101 196 6,255 4,026 5,259Salary Bonuses Taxable Total Total Totaland fees Cash Shares 6 benefits Other 2005 2004 2003US Dollars $’000 $’000 $’000 $’000 $’000 $’000 $’000 $’000Louis Schweitzer 476 – – – – 476 56 4 N/ASir Tom McKillop 1,825 1,527 763 4 6 1 4,125 2,566 2,886David R Brennan 617 5 459 5 230 5 154 5 39 5 1,499 5 N/A N/AJohn Patterson 858 640 320 12 88 1,918 N/A N/AJonathan Symonds 1,056 728 364 14 159 2 2,321 1,764 1,726Sir Peter Bonfield 150 – – – – 150 138 119John Buchanan 126 – – – – 126 111 86Jane Henney 104 – – – – 104 98 79Michele Hooper 90 – – – – 90 78 31 4Joe Jimenez 90 – – – – 90 78 31 4Håkan Mogren 183 – – – – 183 871 3 2,008Erna Möller 104 – – – – 104 98 79Dame Bridget Ogilvie 104 – – – – 104 98 79Marcus Wallenberg 90 – – – – 90 84 74Former DirectorsÅke Stavling – – – – 66 7 66 7 791 7 788Others – – – – – – 490 492Total 5,873 3,354 1,677 184 358 11,446 7,321 8,4781Relates to final payments of relocation allowances. 2 Payment for pension-related tax liabilities. 3 Comprises compensation payment of £450,000 ($818,000) and part year Non-Executive Director’s fee of £29,000 ($53,000). 4 Part year only. 5 Part year only as only appointed as a Director on 14 March 2005. Mr Brennan’s emoluments for the whole of 2005totalled £916,000 ($1,677,000). 6 These figures represent that portion of the bonus required to be deferred into shares for a three year period. 7 Compensation payment.In the above tables, salaries have been converted between sterling and US dollars at the average exchange rate for the year in question. These rateswere GBP/USD: 0.55 (2005), 0.55 (2004) and 0.62 (2003).Some Directors and officers were also granted options to subscribe for Ordinary Shares under the Company’s share option plans and awards underthe AstraZeneca Performance Share Plan (or, in the case of David Brennan, the AstraZeneca US Executive Performance Share Plan). No Director orofficer has a family relationship with any other Director or officer.